Immunotherapy For Triple Negative Breast Cancer Optimal Chemotherapy Partners, New Directors, And Managing Toxicity

Immunotherapy For Triple Negative Breast Cancer Optimal Chemotherapy Partners, New Directors, And Managing Toxicity

0% Complete

Course Content

Credits

  • AMA PRA Category 1 Creditâ„¢Non-CME

Course Details

Duration
0.00 hour
Released
May 14, 2025
Last Review
May 14, 2025
Expires
May 14, 2028

Faculty & Disclosure

Faculty

Priyanka Sharma, MD

Disclosure

Priyanka Sharma, MD discloses no such relationships exist

Accreditation

NA